US2018201645A1PendingUtilityA1

Composition for improving memory, learning ability, and cognitive ability

53
Assignee: BRAINON INCPriority: Dec 21, 2015Filed: May 3, 2016Published: Jul 19, 2018
Est. expiryDec 21, 2035(~9.5 yrs left)· nominal 20-yr term from priority
Inventors:Yong Koo Kang
A61K 38/07A61P 25/28A61P 25/16A61P 25/00A23V 2002/00C07K 5/10A61K 38/08C07K 5/1008C07K 7/06C12N 15/63C12P 21/00C07K 5/1021C07K 5/0806C07K 5/06026A61K 9/14A61K 9/0095A61K 9/0019A23L 33/18
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

There is provided a composition for improving memory, learning ability, and cognitive ability. It has been confirmed that a peptide having a C-terminal region ended to GAG had an effect of improving the memory. In order for the peptide to have the effect, it has been confirmed that the peptide should be a peptide of which the length consists of at least 4 amino acids. Further, it has been confirmed that a peptide of which the length of the peptide having the C-terminal region ended to GAG consists of 5 to 9 amino acids has the same effect. As a result, the peptide of the present invention can be used as the composition for improving memory, learning ability, and cognitive ability.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . (canceled) 
     
     
         4 . A peptide comprising an amino acid sequence having a C-terminal region of GAG, wherein the amino acid sequence of the peptide is GGAG. 
     
     
         5 . A peptide comprising an amino acid sequence having a C-terminal region of GAG, wherein the amino acid sequence of the peptide is AGAG. 
     
     
         6 . A peptide comprising an amino acid sequence having a C-terminal region of GAG, wherein the amino acid sequence of the peptide is QGAG. 
     
     
         7 . (canceled) 
     
     
         8 . (canceled) 
     
     
         9 . (canceled) 
     
     
         10 . (canceled) 
     
     
         11 . (canceled) 
     
     
         12 . (canceled) 
     
     
         13 . (canceled) 
     
     
         14 . (canceled) 
     
     
         15 . (canceled) 
     
     
         16 . (canceled) 
     
     
         17 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.